moderna emergency use authorization

News

Moderna, FDA and COVID

Moderna gets full US approval for COVID vaccine in children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

· 1d

Moderna COVID vaccine gets FDA green light for kids 6 months to 11 years

STAT · 1d

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients

Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...

NBC4 Columbus2y

Moderna Receives FDA Authorization for Emergency Use of Omicron ...

Moderna's Bivalent Booster Shots to be Available Nationwide In Coming DaysmRNA-1273.222 Targets BA.4/.5 Strains of Omicron VariantCAMBRIDGE, MA / ACCESSWIRE / August 31, 2022 / Moderna, Inc ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Moderna, FDA and COVID

Trending now